Ghent, Belgium — 07 October 2026 RheumaFinder, the Ghent-based UZ Gent spin-out developing AI-driven CT screening support for structural bone lesions associated with axial spondyloarthritis (axSpA), has officially achieved ISO 13485:2016 certification — the internationally recognized quality management standard for medical device manufacturers…
We are excited to announce that Wim Van Hecke, PhD, has joined the RheumaFinder board! Wim is a pioneer in AI-driven medical imaging, best known as the founder and CEO of Icometrix—a company that has set the absolute standard for…
Het project CrossCare 2.0 stimuleert, ondersteunt en versnelt innovaties in de zorg. RheumaFinder maakt gebruik van dit programma om de implementatie van AI-gestuurde beeldanalyse voor incidentele detectie van klinisch relevante structurele gewrichtsletsels te optimaliseren binnen ziekenhuizen. Dankzij CrossCare kan RheumaFinder zijn technologie testen, bevragen en doorontwikkelen…
We are pleased to share insights from our co-founder, Prof. dr. Lennart Jans, recently featured in EOS magazine. The article delves into the transformative role of artificial intelligence (AI) in healthcare, a field where RheumaFinder is making significant strides. Click…
We are excited to announce our upcoming conference engagements for the spring season, where RheumaFinder will be actively participating and showcasing our innovative solutions for the incidental detection clinically relevant structural joint lesions. Biotrinity – April 1-2, London Join…
RheumaFinder is thrilled to announce a significant achievement for our co-founder, Thomas Van Den Berghe, who successfully defended his PhD at the Ghent University and Ghent University Hospital on Radiomics, Radiogenomics, and Artificial Intelligence in Musculoskeletal Radiology last week. This…
Very happy to be invited yesterday at MEDVIA's and BioWin's sold-out (!) #sfh2024 congress on AI, Data & Digitalisation and explain RheumaFinder's journey in creating clinical impact by incidental detection of clinically relevant structural joint lesions in everyday medical imaging…
New offices at the Watt Factory in Ghent The RheumaFinder team has moved to new offices at the Watt Factory in Ghent, an office and co-working space that’s home to an entrepreneurial community of companies in tech, healthcare, smart cities…
Dr. Thomas Van Den Berghe's recent study called "Neural network algorithm for detection of erosions and ankylosis on CT of the sacroiliac joints: multicentre development and validation of diagnostic accuracy" was reviewed and published by European Radiology. You can find…
Fund for Scientific Research in Rheumatology (FWRO/FRSR) Prof. Dr. Lennart Jans of RheumaFinder has been named as a recipient from the Fund for Scientific Research in Rheumatology (FWRO/FRSR), managed by the King Baudouin Foundation, for a project conducted in collaboration…